Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis

Open access

Abstract

Background: Studies using positron emission tomography to image striatal dopamine function, have demonstrated that individuals with schizophrenia display increases in presynaptic function. Mesolimbic dysfunction specifically, has previously been suggested to underlie psychotic symptoms. This has not been directly tested in vivo, and the precise anatomical locus of dopamine dysfunction within the striatum remains unclear. The current article investigates the magnitude of dopaminergic abnormalities in individuals with schizophrenia, and determines how the magnitude of abnormality varies across functional subdivisions of the striatum. Methods: EMBASE, PsychINFO, and MEDLINE were searched from January 1, 1960, to December 1, 2016. Inclusion criteria were molecular imaging studies that had measured presynaptic striatal dopamine functioning. Effects sizes for whole striatum and functional subdivisions were calculated separately. The magnitude of difference between functional subdivisions in patients and controls was meta-analyzed. Results: Twenty-one eligible studies were identified, including 269 patients and 313 controls. Individuals with schizophrenia (Hedges' g = 0.68, P < .001) demonstrated elevated presynaptic dopamine functioning compared to controls. Seven studies examined functional subdivisions. These demonstrated significant increases in patients compared to controls in associative (g = 0.73, P = .002) and sensorimotor (g = 0.54, P = .005) regions, but not limbic (g = 0.29, P = .09). The magnitude of the difference between associative and limbic subdivisions was significantly greater in patients compared to controls (g = 0.39, P = .003). Conclusion: In individuals with schizophrenia dopaminergic dysfunction is greater in dorsal compared to limbic subdivisions of the striatum. This is inconsistent with the mesolimbic hypothesis and identifies the dorsal striatum as a target for novel treatment development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/schbul/sbx180

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. The topography of cortical afferents to the striatum illustrating the functional subdivisions.
Fig. 1. The topography of cortical afferents to the striatum illustrating the functional subdivisions.CC BY · PubMed Central
Fig. 2. Forest plot of studies investigating presynaptic dopaminergic function in the whole striatum for individuals with schizophrenia. The forest plot shows the effect size (hedges g) and 95% CI for the difference between patients and controls. There is a significant elevation in schizophrenia with a summary effect size of 0.68.
Fig. 2. Forest plot of studies investigating presynaptic dopaminergic function in the whole striatum for individuals with schizophrenia. The forest plot shows the effect size (hedges g) and 95% CI for the difference between patients and controls. There is a significant elevation in schizophrenia with a summary effect size of 0.68.CC BY · PubMed Central
Fig. 3. Studies of presynaptic dopamine function in individuals with schizophrenia by functional subdivisions. Significant elevations are seen for the associative and sensorimotor, but not limbic subdivisions. In schizophrenia the associative-limbic and sensorimotor-limbic differences are significantly greater in patients than in controls. (A) Effect size and 95% CI of difference in dopamine function in schizophrenia between patients and controls showing significant elevations in patients in associative (g = 0.73) and sensorimotor (g = 0.54) subdivisions but not limbic. (B) Effect sizes and 95% CIs of subdivision differences in schizophrenia between patients and controls. Patients show significantly greater associative-limbic (d = 0.38) and sensorimotor-limbic (d = 0.29) differences compared to controls. (C) Magnitude of patient-control differences in presynaptic dopamine functioning for striatal subdivisions in individuals with schizophrenia (*P < .05 for patient-control comparison), error bars represent 1 SE).
Fig. 3. Studies of presynaptic dopamine function in individuals with schizophrenia by functional subdivisions. Significant elevations are seen for the associative and sensorimotor, but not limbic subdivisions. In schizophrenia the associative-limbic and sensorimotor-limbic differences are significantly greater in patients than in controls. (A) Effect size and 95% CI of difference in dopamine function in schizophrenia between patients and controls showing significant elevations in patients in associative (g = 0.73) and sensorimotor (g = 0.54) subdivisions but not limbic. (B) Effect sizes and 95% CIs of subdivision differences in schizophrenia between patients and controls. Patients show significantly greater associative-limbic (d = 0.38) and sensorimotor-limbic (d = 0.29) differences compared to controls. (C) Magnitude of patient-control differences in presynaptic dopamine functioning for striatal subdivisions in individuals with schizophrenia (*P < .05 for patient-control comparison), error bars represent 1 SE).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 74 references

Research works printed but not linked: 2

  1. Slifstein, 2015, Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia, JAMA Psychiatry, 10032, 1
  2. World Health Organization, 1992, International Classification of Diseases, 10th Edition (ICD-10): Classification of Mental and Behavioural Disorders

Cited by

See all 305

Metadata

Authors
McCutcheon, R., Beck, K., Jauhar, S., & Howes, O. D.
Affiliations
King's College London (GB)
Corresponding author
Howes, Oliver D
Venue
Schizophrenia Bulletin
Published
2017-12-28
Volume
44
Issue
6
Pages
1301-1311
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
OpenAlex
W2777013718
Cited by
305
References
74
Citations by year
2026: 26 · 2025: 49 · 2024: 43 · 2023: 50 · 2022: 45 · 2021: 28 · 2020: 35 · 2019: 22 · 2018: 7
FWCI
2.66
Type
journal article
Language
en
Open access
Locations
  • Schizophrenia Bulletin (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
  • Brain and Behavior Research Foundation
  • Wellcome Trust (094849/Z/10/Z, 200102/Z/15/Z)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
schizophrenia, dopaminergic dysfunction
MeSH terms
Dopamine, Humans, Schizophrenia, Synapses, Neostriatum, Positron-Emission Tomography, Neuroimaging, Ventral Striatum

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis. https://app.cochat.ai/papers/10.1093/schbul/sbx180
The paper
McCutcheon, R., Beck, K., Jauhar, S., & Howes, O. D. (2018). Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbx180

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.